ADC Therapeutics Licenses Proprietary Antibodies from Five Prime ... 4-traders (press release) Under the agreement, ADC Therapeutics plans to initiate preclinical research and development of antibody-drug conjugates using the antibodies licensed from Five Prime immediately, adding to ADC Therapeutics' portfolio of proprietary ADC programs. |
